secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001493152-25-027680
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals announces 1-for-25 reverse stock split effective Dec 16, 2025
--------------------------------------------------------------------------------

- Reverse split reduces outstanding shares 25:1; no change to authorized shares (1B).
- Effective 5:00 p.m. ET Dec 16, 2025; split-adjusted trading begins Dec 17, 2025 under symbol PCSA.
- New CUSIP number 74275C403; fractional shares rounded up to nearest whole share.
- Outstanding options, warrants, and RSUs adjusted proportionally per their terms.
- Stockholders' ownership percentages unchanged except for fractional share rounding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225027680/0001493152-25-027680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225027680/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer